RxDoctor Payments Data

Vershalee Shukla, MD

Radiation Oncology · Scottsdale, AZNPI 1366726788

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $12,180 of the $19,186 with a category attached, or 63.5%. Exact Sciences accounts for 62.8% of it on its own, with 36 other manufacturers making up the rest. 2025 is the largest year on record at $13,345, more than ten times the $844 reported in 2019. Among radiation oncology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,186in general payments, 2019–2025

Across 119 payments — averaging $161.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$12K
  • AstraZeneca$2K
  • Angiodynamics, Inc.$890
  • Histosonics, Inc.$672
  • Varian Medical Systems, Inc.$589
  • Siemens Medical Solutions USA, Inc.$389
  • plus $2K from 31 others

What the payments were for

  • Consulting fees$12,18063%
  • Travel & lodging$3,36618%
  • Food & beverage$3,64019%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,186 in reported general payments places this provider in the 95th percentile of 138 radiation oncology providers in Arizona.

See all radiation oncology providers in Arizona

Medicare billing

Part B allowed, 2024
$564,976
Medicare patients
95
Services billed
3,000

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl44$480

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →